吉林大学学报(医学版)

• 基础研究 • 上一篇    下一篇

缺氧诱导因子-1α基因沉默逆转卵巢癌细胞SKOV3/DDP耐药性的机制

薛惠荣1,王丽萍2,耿嘉男2,崔满华3   


  1. (1. 中国人民解放军第二二二医院妇产科, 吉林 吉林132011;2. 吉林大学药学院实验药理与毒理学教研室,吉林 长春130021;3.吉林大学第二医院妇产科,吉林 长春130041)
  • 收稿日期:2013-05-07 发布日期:2013-11-28
  • 通讯作者: 崔满华 E-mail:(Tel:0431-88796212,E-mail:cuimanhua@126.com)
  • 作者简介:薛惠荣(1972-),女,吉林省吉林市人,副主任医师,主要从事妇科肿瘤基础和临床研究。
  • 基金资助:

    国家自然科学基金资助课题 (30973187)

Mechanism of resistance of ovarian cancer cell SKOV3/DDP reversed by  HIF-1α gene silencing


XUE Hui-rong1,WANG Li-ping2,GENG Jia-nan2,CUI Man-hua3   

  1. (1.Department of Obstetrics and Gynecology,No.222 Hospital,Chinese People’s Liberation Army, Jilin 132011,China;2. Department of Experimental Pharmacology and Toxicology,School of Pharmacy,Jilin University,Changchun 130021,China;3. Department of Obstetrics and Gynecology,Second Hospital,Jilin University,Changchun 130041,China)
  • Received:2013-05-07 Published:2013-11-28

摘要:

目的:观察缺氧诱导因子-1α(HIF-1α)沉默后人卵巢癌细胞顺铂耐药株SKOV3/DDP 的HIF-1α、多药耐药基因1 (MDR1)和B细胞淋巴瘤/白血病-2基因(Bcl-2)mRNA及蛋白产物的表达,探讨HIF-1α逆转SKOV3/DDP耐药性的机制。方法:体外培养卵巢癌细胞株SKOV3(敏感组)及其顺铂耐药株SKOV3/DDP(耐药组),部分耐药株转染HIF-1α干扰质粒 pshRNA-HIF(转染组)及对照质粒pshRNA-Control(对照组)。RT-PCR法检测各组细胞HIF-1α、MDR1和Bcl-2 mRNA表达量;Western blotting和免疫组织化学法测定HIF-1α、P-gp(MDR1基因编码蛋白)和Bcl-2蛋白的表达量。结果:RT-PCR检测,敏感组和转染组HIF-1α、MDR1和Bcl-2 mRNA表达量明显低于耐药组(P<0.05)。Western blotting检测,敏感组和转染组HIF-1α、MDR1和Bcl-2蛋白表达量明显低于耐药组(P<0.05) ;免疫组织化学法,敏感组和转染组HIF-1α、MDR1和Bcl-2蛋白表达量明显低于耐药组(P<0.05);MDR1、Bcl-2 mRNA及蛋白在敏感组与转染组的表达量差异无统计学意义(P>0.05)。HIF-1α表达与MDR1、Bcl-2 mRNA表达量均呈正相关关系(r=0.908,P=0;r=0.916,P=0);HIF-1α表达与P-gp、Bcl-2蛋白表达呈正相关关系(r=0.773,P=0.003;r=0.862,P=0)。结论:HIF-1α沉默逆转人卵巢癌细胞顺铂耐药株SOV3/DDP耐药性可能与MDR1和Bcl-2表达降低有关联。

关键词: 卵巢癌, 缺氧诱导因子-1&alpha, 多药耐药, B细胞淋巴瘤/白血病-2

Abstract:

Abstract:Objective
To observe the  expressions of hypoxia inducible factor-1 alpha (HIF-1α),multidrun resistance(MDR1),and B cell lymphoma/leukemia-2(Bcl-2) mRNA and protein  in human ovarian cancer DDP resistant strain SKOV3/DDP after HIF-1α silencing,and to explore the mechanism of the  resistance of  SKOV3/ DDP reversed by  HIF-1α gene silencing.
Methods The ovarian cancer cell strain SKOV3(sensitivity group) and DDP resistance strain SKOV3/DDP (resistance group)were cultured in vitro and parts of the SKOV3/DDP were transfected with HIF-1α interfere plasmid pshRNA-HIF (transfection group) or control plasmid pshRNA-Control (control group).RT-PCR method was used to detect the expression levels of  HIF-1α,MDR1 and Bcl-2 mRNA;Western blotting and immunohistochemisty methods were used to determine the expression levels of HIF-1α,P-gp (MDR1 gene encoding protein),and Bcl-2 protein in  the cells.Results The expression levels of  HIF-1α,MDR1 and Bcl-2 mRNA   in sensitivity  group and transfection group  were significantly lower than those in resistance group (P<0.05) detected by RT-PCR;the expression levels of HIF-1α,MDR1,and Bcl-2 protein in sensitivity group and transfection group were significantly lower than those in resistance group(P<0.05) determined by Western blotting and immunohistochemistry;the expression levels of MDR1,Bcl-2 mRNA and protein  in sensitivity group and transfection group had no significant difference (P>0.05).The expressions of HIF-1  α and MDR1 and Bcl -2 were closely related(correlation coefficient of mRNA,r=0.908,P=0;r=0.916,P=0;correlation coefficient of protein,r=0.773,P=0.003;r=0.862,P=0).Conclusion The resistance of  ovarian cancer cell SKOV3 / DDP HIF-1 α gene silencing may be related to the  down-regulation of   MDR1 and Bcl-2 expressions.

Key words: ovarian tumor, hypoxia inducible factor-1 alpha, multidrug resistance, B cell lymphoma/leukemia-2

中图分类号: 

  • R711.75